IRA Capital
VC Fund
IRA Capital is a privately-held real estate investment and management company that focuses on creating and maximizing value through the strategic acquisition and management of real estate assets. It primarily invests in commercial real estate assets with an overweight concentration within the medical and healthcare real estate sector. Thefirm's mission is to be the first and foremost preserve investor capital and to deliver attractive risk-adjusted returns while making a positive impact on the communities in which the company invests.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries IRA Capital invests in
Stages IRA Capital invests in
Countries IRA Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amer F. Kasm
|
|||
Mohannad Malas
|
|||
Investment Focus
Industry
- Software 2 (40%)
- Health Care 2 (40%)
- Personal Health 2 (40%)
- B2B 1 (20%)
- CRM 1 (20%)
Stage
- Series C 2 (40%)
- Seed 1 (20%)
- Series A 1 (20%)
Country
- United States 3 (60%)
- Hong Kong 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Amer F. Kasm
Principal and Co-Founder
|
Principal and Co-Founder | Total investments: 0 | Find email | |
|
Mohannad Malas
Principal and Co Founder
|
Principal and Co Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Outcomes4Me
|
Outcomes4Me provides an AI-powered digital platform designed to assist cancer patients in managing their care. The platform integrates clinical guidelines, genomic data, and clinical trial information to offer personalized treatment options. Patients can access features such as symptom tracking, medication management, and tailored clinical trialmatching. Outcomes4Me also facilitates the organization and understanding of medical records, enabling users to make informed decisions in collaboration with their healthcare providers. The platform is developed in collaboration with experts in oncology and aims to support patients throughout their treatment journey. | $21M / Series A / May 29, 2025 | |
Yobi
|
Yobi centralizes all your customer conversations into one inbox, no matter the channel, from your preferred platform. Simple and powerful, you can talk to your customers over any channel, and share and review conversations with your team, anywhere in the world.Yobi syncs all your contacts from popular CRMs and your messages from social mediachannels like Facebook, Messenger, Twitter, Instagram, HubSpot, Pipedrive, and more. It helps you optimize customer conversations from calls, text messages, notes, and social media platform from one app.Yobi works wherever you work, on iOS, Android, Windows, Mac OS, and on the web. | $2.4M / Seed / Feb 01, 2023 | |
Oddup
|
Oddup provides startup, investor, sector, and ecosystem data, insights, and analyses in 34 major cities across the globe. Oddup also provides cryptocurrency listings and price targets, ICO analysis, and the Oddup Indexes, which track real-time trends across the startup landscape.Oddup is an indispensable resource for investors, investment banks,venture capitalists, accelerators, corporate innovators and management consultancies seeking detailed information and greater clarity in the fragmented and foggy startup sector, the ICO landscape, or the cryptocurrency investment market.Oddup provides comprehensive data and analyses, and exhaustive deep dives of varied ecosystems, sectors, and regions of the world.They also delve into the profiles of thousands of startups to give investors a curated view on their health and potential success in a single score. Additionally, they also provide curated, in-depth analysis of all past, ongoing, and upcoming ICOs, and analysis of active cryptocurrencies.They track and explore hundreds of ICOs and cryptocurrencies to give investors a curated list that simplifies this increasingly preferred fundraising method. | $12.8M / Series C / Aug 31, 2021 | |
|
Outcomes4Me
|
Outcomes4Me provides an AI-powered digital platform designed to assist cancer patients in managing their care. The platform integrates clinical guidelines, genomic data, and clinical trial information to offer personalized treatment options. Patients can access features such as symptom tracking, medication management, and tailored clinical trialmatching. Outcomes4Me also facilitates the organization and understanding of medical records, enabling users to make informed decisions in collaboration with their healthcare providers. The platform is developed in collaboration with experts in oncology and aims to support patients throughout their treatment journey. | $12M / Series A / Apr 28, 2021 | |
Heal
|
At Heal, we believe improving health outcomes starts by meeting patients where they're most comfortable: at home. That’s why we provide value-based, in-home primary care to seniors on Medicare and select Medicare Advantage plans. Heal’s service model allows board-certified doctors and nurse practitioners to spend more time with their patients,so care is never rushed, and a strong patient-provider relationship is established.We serve seniors at all stages of their health journey, from preventive care -- like flu shots and annual physicals -- to treating common illnesses and managing chronic conditions. Our services also include telemedicine visits and remote health monitoring, so getting quality care when its needed is easier than ever.With easy and convenient phone support for scheduling or other questions, we offer appointments 8am-6pm, 7 days/week – including weekends and holidays. | $20M / Series C / May 22, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does IRA Capital invest in?
IRA Capital invests primarily in Software, Health Care and Personal Health startups, most often at Series C and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact IRA Capital?
Public channels for IRA Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at IRA Capital?
The team at IRA Capital includes Amer F. Kasm (Principal and Co-Founder) and Mohannad Malas (Principal and Co Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
